GT-Preis des Arbeitskreises Alternativmethoden

Barbara Birk

In vitro testing of angiogenesis by a growth-factor free human based co-culture


GT-Preis des Arbeitskreises Computational Toxicology

Anika Liu

The Adverse Outcome Pathway (AOP) framework aims to formalize knowledge on how molecular initiating events are linked to adverse outcomes, through key events on different biological levels.


GT-Preis des Arbeitskreises Regulatorische Toxikologie - stellvertretend für die Beratungskommission der GT

Claudia Röhl

New aspects in deriving health based guidance values for bromate in swimming pool water


GT-Preis des Arbeitskreises Respiratorische Toxikologie

Paula Vacarallo

MicroRNA-21 as a potential therapeutic target in Idiopathic Pulmonary Fibrosis


GT-Preis des Arbeitskreises Emerging Topics

Holger Sieg

Food Safety Research and Risk Assessment of Submicro- and Nanoplastics


GT-Preis des Arbeitskreises Kanzerogenese

Viktoria Klara Wandt

Trace Elements, Ageing and Sex: Impact on Genome Stability


GT-Preis (Vortrag)

Alina Göpfert

Establishment of an in vitro Transgenic Rodent assay for the detection of potential mutagens


GT-Toxicology Award

Horst Thiermann

Der Preis wird für besondere wissenschaftliche Leistungen anhand erschienener Publikationen vergeben.


GT-Toxins Award

Katharina Sessler

The enzyme subunit SubA of Shiga Toxin-Producing E. coli strains demonstrates comparable intracellular transport and cytotoxic activity as the holotoxin SubAB


Young Investigator Award des Thieme Verlags

Maximilian Steinberg

Validation of an animal replacement assay for in-vitro diagnostics of botulism in humans


Young Scientist Toxicology Merck Award

Jennifer Strehse

Munition im Meer: Auswirkungen auf die marine Ökosphäre – Überwachungsmöglichkeiten mittels Biomonitoring und molekularem Biomarker


Young Scientist Award

Rick Raudszus

The novel TRPV2-selective blocker X10056 inhibits phagocytosis and lipopolysaccharide-induced migration of primary macrophages


Marleen Meyer

OCT1 of mice and men: Differences in metformin and thiamine uptake – Structural causes and potential clinical consequences for hepatic metformin concentrations